million, decreased in amount of THB 118.54 million or 34. 71% down from THB 341. 50 million in 2Q2019. The EPS of 2Q2020 was THB 0. 18 per share. The decrease in consolidated net profit was primarily driven

THB 2.6B. • Strong performance for Combined PET, given COVID disruption, driven by strong PET demand, higher Integrated PET spread, lower costs, improved PIA margin. • Integrated Oxides & Derivatives

income amounted to Baht 5,594 million, an increase of 26.0% driven by the increase in net interest income of 15.9% with non-interest income also increasing by 48.3% from the increase in both net fees and

, driven mainly by exports and government spending. However, the business sector remained mired in uncertainty in terms of new modes of competition, a broader marketplace within the ASEAN Economic Community

consideration for the assets acquired Value of the Company’s securities paid-up shares None Ref. WINNER 0009/20108 Page 5 of 8 Factory is located in Muang district, Chachoengsao province and authorized

located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international

, At-Ze distributed medical care products under brand name “Aesthetic Zecret”. Factory is located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine

authorized directors who can sign to bind the Company, as nominated by SUTGH; (5) The Office of Securities and Exchange Commission (the “SEC”) approves the offering of newly issued ordinary shares on a Private

Chandranipapongse) Company Secretary Authorized Signature on behalf of the Company

. The Company registered the increase of capital with the Ministry of Commerce on 25 December 2019 and authorize the Board of Directors or the authorized director on behalf of the Company for the power to